References
- Paclitaxel is the generic name for Taxol, which is now a registered trademark.
- J. Am. Chem. Soc. v.93 Wani, M. C.;Taylor, H. L.;Wall, M. E.;Coggon, P.;McPhail, A. T.
- J. Nat. Cancer Inst. v.82 Rowinsky, E. K.;Cazenave, L. A.;Donehower, R. C.
- J. Nat. Cancer Inst. v.83 Holmes, F. A.;Walters, R. S.;Theriault, R. L.;Forman, A. D.;Newton, L. K.;Raber, M. N.;Buzdar, A. U.;Frye, D. K.;Hortobagyi, G. N.
- Ann. Repts. Med. Chem. Suffness, M.;Bristol, J. A.(Ed.)
- J. Med. Chem. v.34 Swindell, C.;Krauss, N. E.;Horwitz, S. B.;Ringel, I.
-
J. Med. Chem.
v.34
$Gu\'{e}ritte-Voegelein$ , F.;$Gu\'{e}nard$ , D.;Lavelle, F.;Le Goff, M.-T.;Mangatal, L.;Potier, P. - Chem. Rev. v.89 Hart, D.;Ha, D.-C.
- Tetrahedron Lett. v.25 Georg, G. I.
- Eur. Pat. Appl. EP 400,971, Holton, R. A.
- Tetrahedron v.48 Ojima, I.;Habus, I.;Zaho, M.;Zucco, M.;Park, Y. H.;Sun, C. M.;Brigaud, T.
-
Angew. Chem. Int. Ed. Engl.
v.28
$J\"{a}ger$ , V.;Wehner, V. - Tetrahedron v.39 Schubert, T.;Kunisch, F.;Welzel, P.
- Tetrahedron Lett. v.32 Cainelli, G.;Giacomini, D.;Mezzina, E.;Panunzio, M.;Zarantonello, P.
- Tetrahedron Lett. v.33 Cainelli, G.;Giacomini, D.;Panunzio, M.;Zarantonello, P.
- Angew. Chem. Int. Ed. Engl. v.25 Yamamoto, Y.
- Angew. Chem. Int. Ed. Engl. v.34 Cainelli, G.;Giacomini, D.
- Bioorg. Med. Chem. Lett. v.3 Georg, G. I.;Cheruvallath, Z. S.;Harriman, G. C. B.;Hepperle, M.
- Tetrahedron Lett. v.34 Chaudhary, A. G.;Kingston, D. G. I.
-
Bioorg. Med. Chem. Lett.
v.4
Margraff, R.;
$B\'{e}zard$ , D.;Bourzat, J-D.;Commercon, A.
Cited by
- Synthesis and antitumor activity of DNA binding cationic porphyrin–platinum(II) complexes vol.44, pp.8, 2000, https://doi.org/10.1016/s0040-4039(03)00022-4
- Tuning the Activity of Platinum(IV) Anticancer Complexes through Asymmetric Acylation vol.55, pp.17, 2000, https://doi.org/10.1021/jm300580y
- Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands vol.42, pp.24, 2000, https://doi.org/10.1039/c3dt50751c
- Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance vol.10, pp.1, 2000, https://doi.org/10.1002/cmdc.201402353
- Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs vol.12, pp.4, 2000, https://doi.org/10.1002/cmdc.201600577
- Exploring diversity in platinum(iv) N-heterocyclic carbene complexes: synthesis, characterization, reactivity and biological evaluation vol.47, pp.33, 2000, https://doi.org/10.1039/c8dt02113a